BLUME-JENSEN PETER (President and CEO) reported 1 transaction at ACRIVON THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2026ACC: 0000905148-26-001010
DirectorOfficer· President and CEO
Since Mar 2026
-14.27K
Net shares
Net seller
$21.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
14.27K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.27K
Price / share
$1.53
Trade value
$21.83K
% of position
0.7%
2/21/2026
2.09M→2.08M
Total
Net shares
−14.27K
Net value
-$21.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2026 | F · Tax Withholding | −14.27K | $1.53 | $21.83K | 0.7% | 2.09M | 2.08M |
| Total | −14.27K | -$21.83K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned314.13K
Total
314.13K indirect314.13K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 314.13K | Indirect |
| Total | 314.13K | 314.13K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported